Indian Institute of Chemical Technology (IICT), Hyderabad, is collaborating with another Hyderabad-based integrated pharmaceutical company, LAXAI Life Sciences, to develop and manufacture APIs and drug intermediates.
Daily Current Affairs Quiz 2020
Key-Points
The collaboration will use the know-how for the commercial manufacturing of the products.
LAXAI Life Sciences will be one of the first few to commercialize these products.
The manufacturing of these APIs and intermediates will be taken up at US Food and Drug Administration (USFDA)/Good manufacturing practice (GMP) approved plants held by LAXAI through its subsidiary, Therapiva Private Limited.
Active pharmaceutical ingredients (APIs) and intermediates are the key components of any drug that produces the intended effects. India is largely dependent especially on China for the supply of APIs and drug intermediates.
